Janus Henderson Small Cap Growth .../ US47103U1007 /
1/15/2021 10:15:00 PM | Chg. -0.9083 | Volume | Bid1/15/2021 | Ask1/15/2021 | High | Low |
---|---|---|---|---|---|---|
66.3417USD | -1.35% | 9,867 Turnover: 516,044.6578 |
66.3200Bid Size: 700 | 66.4700Ask Size: 800 | 67.2500 | 66.2401 |
GlobeNewswire
1/7
LEXEO Therapeutics Launches with $85 Million Series A Financing to Develop Gene Therapies for Rare a...
GlobeNewswire
1/4
Novus Therapeutics Announces Name Change to Eledon Pharmaceuticals; Provides Corporate Update and Ou...
GlobeNewswire
11/30/2020
Sunesis Pharmaceuticals and Viracta Therapeutics Announce Definitive Merger Agreement
GlobeNewswire
10/5/2020
Chinook Therapeutics Closes Merger with Aduro Biotech and Completes $115 Million Private Placement F...
GlobeNewswire
8/11/2020
Larimar Therapeutics Reports Second Quarter 2020 Operating and Financial Results
GlobeNewswire
7/1/2020
Annexon Closes $100 Million Financing to Advance Broad Pipeline of Classical Complement Therapeutics
GlobeNewswire
6/22/2020
iTeos Therapeutics Presents Preclinical Data for its Anti-TIGIT antibody, EOS-448, at the AACR II Vi...
GlobeNewswire
6/15/2020
iTeos Therapeutics to Present Preclinical Data for its Anti-TIGIT antibody, EOS-448, at the AACR II ...
GlobeNewswire
5/29/2020
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
GlobeNewswire
4/27/2020
iTeos Therapeutics Presents Data from First-in-Human Study of A2A Receptor Antagonist at AACR Virtua...
GlobeNewswire
4/27/2020
iTeos Therapeutics Presents Data from First-in-Human Study of A2A Receptor Antagonist at AACR Virtua...
GlobeNewswire
4/20/2020
iTeos Therapeutics to Present Data from First-in-Human Study of A2A Receptor Antagonist at AACR Virt...